# Fluid Resuscitation in Patients Suffering From Burns Injury

> **NCT01689506** · PHASE4 · TERMINATED · sponsor: **Fresenius Kabi** · enrollment: 11 (actual)

## Conditions studied

- Burns

## Interventions

- **DRUG:** Volulyte
- **DRUG:** Human Serum Albumin

## Key facts

- **NCT ID:** NCT01689506
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Study stopped due to low recruitment
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01689506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01689506, "Fluid Resuscitation in Patients Suffering From Burns Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01689506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*